1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants

Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants

Summary

GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants” which essentially provides insights into the seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2018. The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region. Further, the geographical distribution of seasonal influenza vaccines across Japan, Australia, New Zealand, China, Taiwan, Philippines, Hong Kong, Malaysia, India and Singapore are also provided in the report. The report offers a clear view of the regulatory landscape in the Asia-Pacific countries. The report also reveals the seasonal influenza vaccine R&D pipeline and offers profiles of promising vaccines. The report explores the competitive landscape including profiles for top companies. Finally, the key trend analysis on mergers and acquisitions, and licensing agreements involving seasonal influenza vaccines is also presented.

Treatment of seasonal influenza is dominated by two categories of treatment options, vaccines and antiviral therapies. In the recent years it was observed that demand for seasonal influenza vaccines have increased due to changed perception of patient population. The patient population is of the opinion that preventive healthcare is better compared to curative healthcare; this led to increased demand of vaccines in Asia-Pacific region. Asia-Pacific (APAC) region is an attractive market for seasonal influenza vaccine manufacturers. Major drivers in the market is increasing awareness, increasing vaccination coverage in the APAC countries and rising government support for immunization against seasonal influenza. Major restraints of the market are variable demand and limited production capacity. Traditional egg based manufacturing of seasonal influenza vaccines is being replaced with cell culture vaccines. Cell culture based production of vaccines is expected to reduce the problems associated with the production and use of seasonal influenza vaccines which will further increase the vaccination coverage in the APAC region.

GBI Research Analysis shows that the seasonal influenza vaccine market in the APAC Region is a fast growing market. This is due to increased vaccination coverage against seasonal influenza in the region. GBI Research forecasts the market to grow at double digit Compounded Annual Growth Rate (CAGR) of 9% during the period 2011–2018 from $1,015m in 2011 to $1,879m by 2018. This growth is driven by factors such as increasing awareness on influenza caused by threat of pandemic influenza, increasing vaccination coverage because of the governments’ support, growing population in the APAC region and entry of novel vaccines and production technologies.

GBI Research finds that the Philippines’ seasonal influenza vaccine market is the most attractive in the seasonal influenza vaccine market for Asia-Pacific region both in terms of value and growth rate. Other attractive markets in terms of growth rate are Malaysia’s and Singapore’s seasonal influenza vaccine markets. Australia’s seasonal influenza vaccine market is also a large sized attractive market forecast to grow at a healthy growth rate during the period 2011–2018. In-depth analysis of the report is based on propriety databases, primary and secondary research and in house analysis by the GBI Research team of experts.

GBI Research analysis shows that the R&D pipeline for the seasonal influenza vaccines is moderately strong with approximately 50% of the pipeline in the Phase II and Phase III. The major vaccine manufacturers are focused upon acquiring new technologies and strengthening their presence in the market by collaborating with or acquiring small and medium sized biotech companies that have strong vaccine candidates in their pipeline. The R&D activity also indicates development of new technologies and novel vaccines that can revolutionize the market in near future.

Scope

- The report analyses vaccination patterns, market characterization, regulatory landscape, pipeline analysis, competitive landscape and key M&A trends in the seasonal influenza vaccine market in the APAC region.
- Data and analysis on the seasonal influenza vaccine market in the Asia-Pacific Region including Japan, Australia, New Zealand, China, Taiwan, Philippines, Malaysia, Hong Kong, India and Singapore.
- Market forecasts for the seasonal influenza vaccines from 2011 to 2018
- Market Data on geographical landscape including country wise vaccination coverage, public and private contribution on total doses, price of vaccine, market size and market share.
- Key drivers and restraints that have created significant impact on the market.
- Regulatory landscape including the pharmaceutical product approval process and overview of regulatory authorities in the countries in Asia-Pacific region
- Competitive landscape of the seasonal influenza vaccine market in Asia-Pacific region including top companies profiles. The key companies studied in this report are Sanofi Pasteur, Abbott Laboratories, GlaxoSmithKline Biologicals, Novartis Vaccines, CSL Biotherapies and Crucell.
- Key M&A activities, Licensing Agreements, that have taken place between 2007 and 2012 in the seasonal influenza vaccine market.

Reasons to buy

The report will aid business development and marketing executives strategizing their product launches -
- Build effective strategies to launch their pipeline products by identifying potential geographies.
- Exploit in-licensing and out-licensing opportunities by identifying products that might probably fill their portfolio gaps.
- Develop key strategic initiatives by studying the key strategies of top competitors.
- Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class vaccines with more efficacy and better safety.

Table Of Contents

Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
Table of Contents

1 Table of Contents 5
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
3 Seasonal Influenza Vaccine Market in Asia-Pacific - Market Overview 14
3.1 Market Characterization and Forecasts 14
3.2 Revenue by Geographical Segmentation 15
4 Seasonal Influenza Vaccine Market in Asia-Pacific - Australia 17
4.1 Registration Process and Regulations 17
4.2 Market Characterization and Forecasts 20
4.3 Cost of Vaccination 21
4.4 Vaccination Pattern 22
4.4.1 Population 22
4.4.2 Vaccinated Population Contribution 23
4.4.3 Vaccination Coverage 24
4.4.4 Number of Doses per Person 24
4.4.5 Total Number of Doses 25
4.4.6 Dose Contribution 25
4.5 Drivers and Barriers 26
4.5.1 Drivers 26
4.5.2 Restraints 26
5 Seasonal Influenza Vaccine Market in Asia-Pacific - China 27
5.1 Registration Process and Regulations 27
5.2 Market Characterization and Forecasts 29
5.3 Cost of Vaccination 30
5.4 Vaccination Pattern 31
5.4.1 Population 31
5.4.2 Vaccinated Population Contribution 32
5.4.3 Vaccination Coverage 33
5.4.4 Number of Doses per Person 33
5.4.5 Total Number of Doses 34
5.4.6 Dose Contribution 34
5.5 Competitive Landscape 35
5.6 Drivers and Barriers 35
5.6.1 Drivers 35
5.6.2 Barriers 35
6 Seasonal Influenza Vaccine Market in Asia-Pacific - Hong Kong 36
6.1 Registration Process and Regulations 36
6.2 Market Characterization and Forecasts 38
6.3 Cost of Vaccination 39
6.4 Vaccination Pattern 40
6.4.1 Population 40
6.4.2 Vaccinated Population Contribution 41
6.4.3 Vaccination Coverage 42
6.4.4 Number of Doses per Person 42
6.4.5 Total Number of Doses 43
6.4.6 Dose Contribution 43
6.5 Competitive Landscape 44
6.6 Drivers and Barriers 45
6.6.1 Drivers 45
6.6.2 Restraints 45
7 Seasonal Influenza Vaccine Market in Asia-Pacific - India 46
7.1 Registration Process and Regulations 46
7.2 Market Characterization and Forecasts 49
7.3 Cost of Vaccination 50
7.4 Drivers and Barriers 51
7.4.1 Drivers 51
7.4.2 Barriers 51
8 Seasonal Influenza Vaccine Market in Asia-Pacific - Japan 52
8.1 Registration Process and Regulations 52
8.2 Market Characterization and Forecasts 54
8.3 Cost of Vaccination 55
8.4 Vaccinated Population 56
8.4.1 Population 56
8.4.2 Vaccinated Population Contribution 57
8.4.3 Vaccination Coverage 58
8.5 Drivers and Restraints 60
8.5.1 Drivers 60
8.5.2 Barriers 61
9 Seasonal Influenza Vaccine Market in Asia-Pacific - Malaysia 62
9.1 Registration Process and Regulations 62
9.2 Market Characterization and Forecasts 64
9.3 Cost of Vaccination 65
9.4 Vaccination Pattern 66
9.4.1 Population 66
9.4.2 Vaccinated Population Contribution 67
9.4.3 Vaccination Coverage 68
9.4.4 Number of Doses per Person 68
9.4.5 Total Number of Doses 69
9.4.6 Dose Contribution 69
9.5 Competitive Landscape 70
9.6 Drivers and Barriers 71
9.6.1 Drivers 71
9.6.2 Barriers 71
10 Seasonal Influenza Vaccine Market in Asia-Pacific - New Zealand 72
10.1 Registration Process and Regulations 72
10.2 Market Characterization and Forecasts 74
10.3 Cost of Vaccination 75
10.4 Vaccination Pattern 76
10.4.1 Population 76
10.4.2 Vaccinated Population Contribution 77
10.4.3 Vaccination Coverage 78
10.4.4 Number of Doses per Person 78
10.4.5 Total Number of Doses 79
10.4.6 Dose Contribution 79
10.5 Competitive Landscape 80
10.6 Drivers and Barriers 81
10.6.1 Drivers 81
10.6.2 Barriers 81
11 Seasonal Influenza Vaccine Market in Asia-Pacific - Philippines 82
11.1 Registration Process and Regulations 82
11.2 Market Characterization and Forecasts 84
11.3 Cost of Vaccination 85
11.4 Vaccination Pattern 86
11.4.1 Population 86
11.4.2 Vaccinated Population Contribution 87
11.4.3 Vaccination Coverage 88
11.4.4 Number of Doses per Person 88
11.4.5 Total Number of Doses 89
11.4.6 Dose Contribution 89
11.5 Competitive Landscape 90
11.6 Drivers and Barriers 91
11.6.1 Drivers 91
11.6.2 Restraints 91
12 Seasonal Influenza Vaccine Market in Asia-Pacific - Singapore 92
12.1 Registration Process and Regulations 92
12.2 Market Characterization and Forecasts 93
12.3 Cost of Vaccination 94
12.4 Vaccination Pattern 95
12.4.1 Population 95
12.4.2 Vaccinated Population Contribution 96
12.4.3 Vaccination Coverage 97
12.4.4 Number of Doses per Person 97
12.4.5 Total Number of Doses 98
12.4.6 Dose Contribution 98
12.5 Competitive Landscape 99
12.6 Drivers and Barriers 100
12.6.1 Drivers 100
12.6.2 Barriers 100
13 Seasonal Influenza Vaccine Market in Asia-Pacific - Taiwan 101
13.1 Registration Process and Regulations 101
13.2 Market Characterization and Forecasts 103
13.3 Cost of Vaccination 104
13.4 Vaccination Pattern 105
13.4.1 Population 105
13.4.2 Vaccinated Population Contribution 106
13.4.3 Vaccination Coverage 107
13.4.4 Number of Doses per Person 107
13.4.5 Total Number of Doses 108
13.4.6 Dose Contribution 108
13.5 Competitive Landscape 109
13.6 Drivers and Barriers 110
13.6.1 Drivers 110
13.6.2 Restraints 110
14 Seasonal Influenza Vaccine Market in Asia-Pacific - Pipeline Analysis 111
14.1 Pipeline Analysis by Phase 111
14.2 Product Profiles of Promising Molecules 116
14.2.1 Optaflu 117
14.2.2 GSK2186877A 117
14.2.3 Intanza/Flu-ID 118
14.2.4 Fluad Pediatric 119
14.2.5 FluBlok 119
14.3 Product Profiles of Marketed Products 120
14.3.1 Fluarix 120
14.3.2 Vaxigrip 120
14.3.3 Influvac 120
14.3.4 Fluvax 120
14.3.5 Agrippal 120
15 Seasonal Influenza Vaccine Market in Asia-Pacific - Competitive Landscape 121
15.1 Sanofi Pasteur 121
15.2 GlaxoSmithKline Biologicals 121
15.3 Abbott Laboratories (Solvay Pharmaceuticals) 121
15.4 CSL Biotherapies 121
15.5 Novartis Vaccines 122
15.6 Crucell N.V. (Berna Biotech) 122
16 Seasonal Influenza Vaccine Market in Asia-Pacific - Strategic Consolidations 123
16.1 Overview 123
16.2 Major Merger and Acquisition Deals, 2007-2012 123
16.2.1 AstraZeneca Acquires Medimmune 124
16.2.2 Sanofi-Aventis (now Sanofi) Acquires Acambis 124
16.2.3 Mymetics Acquires Virosome Biologicals 124
16.2.4 Simcere Pharmaceutical Acquires a Majority Stake in Jiangsu Yanshen Biological Technology Stock 124
16.2.5 Novartis Completes Acquisition of 85% Stake in Zhejiang Tianyuan 125
16.2.6 Abbott Laboratories Acquires Solvay Pharmaceuticals 125
16.2.7 Nutri Pharma Acquires a Majority Stake in Bionor Immuno 125
16.2.8 Johnson and Johnson Acquires Crucell 125
16.2.9 GlaxoSmithKline to Acquire Remaining Interest in Shenzhen GSK-Neptunus Biologicals 125
16.3 MandA Deals by Geography 126
16.4 Major Licensing Agreements, 2007-2012 127
16.4.1 Crucell Enters into License Agreement with Adimmune Corporation 127
16.4.2 MedImmune Enters into Licensing Agreement with Sanofi Pasteur 127
16.4.3 Vivalis Enters into Licensing Agreement with GlaxoSmithKline 127
16.4.4 Vivalis Enters into Licensing Agreement with Nobilon International 127
16.4.5 MedImmune Enters into Licensing Agreement with GlaxoSmithKline 127
16.4.6 Hemispherx Biopharma Enters into Licensing Agreement with Biken 128
16.4.7 MedImmune Enters into Licensing Agreement with Biken 128
16.4.8 MedImmune Enters into Licensing Agreement with Omninvest 128
16.4.9 OPKO Health Enters into Licensing Agreement with Academia Sinica 128
16.4.10 Altravax Enters into Licensing Agreement with Maxygen 128
16.4.11 Protein Sciences Expands its Licensing Agreement with UMN Pharma for FluBlok and PanBlok 128
16.4.12 NasVax Extends its Research Agreement with Novartis 129
16.4.13 iBio Enters into Licensing Agreement with G-Con 129
16.5 Licensing Deals by Geography 130
17 Seasonal Influenza Vaccine Market in Asia-Pacific - Appendix 131
17.1 Market Definitions 131
17.2 Abbreviations 131
17.3 Bibliography 132
17.4 Research Methodology 133
17.4.1 Coverage 133
17.4.2 Secondary Research 134
17.4.3 Primary Research 134
17.5 Therapeutic Landscape 135
17.5.2 Market Size by Geography 136
17.6 Geographical Landscape 137
17.7 Pipeline Analysis 137
17.8 Competitive Landscape 137
17.8.1 Expert Panel Validation 137
17.9 Contact Us 137
17.10 Disclaimer 137



List of Tables

Table 1: Seasonal Influenza Vaccine Market, APAC Region, Revenue Forecast ($bn), 2011-2018 14
Table 2: Seasonal Influenza Vaccine Market, APAC Region, Revenue Forecast by Geography ($m), 2011-2018 15
Table 3: Seasonal Influenza Vaccine Market, Australia, Revenue Forecast ($m), 2011-2018 20
Table 4: Seasonal Influenza Vaccine Market, Australia, Vaccination Cost Forecast ($), 2011-2018 21
Table 5: Seasonal Influenza Vaccine Market, Australia, Population Forecast by Age Group (million), 2011-2018 22
Table 6: Seasonal Influenza Vaccine Market, Australia, Vaccinated Population Forecast by Age Group (%), 2011-2018 23
Table 7: Seasonal Influenza Vaccine Market, Australia, Vaccination Coverage Forecast by Age Group (million), 2011-2018 24
Table 8: Seasonal Influenza Vaccine Market, Australia, Number of Doses Forecast by Age Group (million), 2011-2018 25
Table 9: Seasonal Influenza Vaccine Market, China, Revenue Forecast ($m), 2011-2018 29
Table 10: Seasonal Influenza Vaccine Market, China, Vaccination Cost Forecast ($), 2011-2018 30
Table 11: Seasonal Influenza Vaccine Market, China, Population Forecast by Age Group (million), 2011-2018 31
Table 12: Seasonal Influenza Vaccine Market, China, Vaccinated Population Forecast (%), 2011-2018 32
Table 13: Seasonal Influenza Vaccine Market, China, Vaccination Coverage Forecast (million), 2011-2018 33
Table 14: Seasonal Influenza Vaccine Market, China, Number of Doses Forecast (million), 2011-2018 34
Table 15: Seasonal Influenza Vaccine Market, Hong Kong, Revenue Forecast ($m), 2011-2018 38
Table 16: Seasonal Influenza Vaccine Market, Hong Kong, Vaccination Cost Forecast ($), 2011-2018 39
Table 17: Seasonal Influenza Vaccine Market, Hong Kong, Population Forecast by Age Group, (million), 2011-2018 40
Table 18: Seasonal Influenza Vaccine Market, Hong Kong, Vaccinated Population Forecast by Age Group (%), 2011-2018 41
Table 19: Seasonal Influenza Vaccine Market, Hong Kong, Vaccination Coverage Forecast (‘000), 2011-2018 42
Table 20: Seasonal Influenza Vaccine Market, Hong Kong, Number of Doses Forecast by Age Group (‘000), 2011-2018 43
Table 21: Seasonal Influenza Vaccine Market, India, Revenue Forecast ($m), 2011-2018 49
Table 22: Seasonal Influenza Vaccine Market, India, Vaccination Cost Forecast ($), 2011-2018 50
Table 23: Seasonal Influenza Vaccine Market, Japan, Revenue Forecast ($m), 2011-2018 54
Table 24: Seasonal Influenza Vaccine Market, Japan, Vaccine Cost ($), 2011-2018 55
Table 25: Seasonal Influenza Vaccine Market, Japan, Population Forecast by Age Group (million), 2011-2018 56
Table 26: Seasonal Influenza Vaccine Market, Japan, Vaccination Coverage Forecast by Age Group (%), 2011-2018 57
Table 27: Seasonal Influenza Vaccine Market, Japan, Overall Vaccination Coverage (million), 2011-2018 58
Table 28: Seasonal Influenza Vaccine Market, Japan, Vaccination Coverage by Age Group (million), 2011-2018 58
Table 29: Seasonal Influenza Vaccine Market, Japan, Number of Doses Forecast (million), 2011-2018 58
Table 30: Seasonal Influenza Vaccine Market, Japan, Number of Doses Forecast by Age Group (million), 2011-2018 59
Table 31: Seasonal Influenza Vaccine Market, Malaysia, Revenue Forecast ($m), 2011-2018 64
Table 32: Seasonal Influenza Vaccine Market, Malaysia, Vaccination Cost Forecast ($), 2011-2018 65
Table 33: Seasonal Influenza Vaccine Market, Malaysia, Population Forecast by Age Group (million), 2011-2018 66
Table 34: Seasonal Influenza Vaccine Market, Malaysia, Vaccinated Population Forecast by Age Group (%), 2011-2018 67
Table 35: Seasonal Influenza Vaccine Market, Malaysia, Vaccination Coverage Forecast by Age Group (‘000), 2011-2018 68
Table 36: Seasonal Influenza Vaccine Market, Malaysia, Number of Doses Forecast by Age Group (‘000), 2011-2018 69
Table 37: Seasonal Influenza Vaccine Market, New Zealand, Revenue Forecast ($m), 2011-2018 74
Table 38: Seasonal Influenza Vaccine Market, New Zealand, Vaccination Cost Forecast (%), 2011-2018 75
Table 39: Seasonal Influenza Vaccine Market, New Zealand, Population by Age Group Forecast (million), 2011-2018 76
Table 40: Seasonal Influenza Vaccine Market, New Zealand, Vaccinated Population Forecast (%), 2011-2018 77
Table 41: Seasonal Influenza Vaccine Market, New Zealand, Vaccination Coverage Forecast (‘000), 2011-2018 78
Table 42: Seasonal Influenza Vaccine Market, New Zealand, Number of Doses Forecasts (‘000), 2011-2018 79
Table 43: Seasonal Influenza Vaccine Market, Philippines, Revenue Forecast ($m), 2011-2018 84
Table 44: Seasonal Influenza Vaccine Market, Philippines, Vaccination Cost Forecast ($), 2011-2018 85
Table 45: Seasonal Influenza Vaccine Market, Philippines, Population Forecast (million), 2011-2018 86
Table 46: Seasonal Influenza Vaccine Market, Philippines, Vaccinated Population Forecast (%), 2011-2018 87
Table 47: Seasonal Influenza Vaccine Market, Philippines, Vaccination Coverage Forecast (million), 2011-2018 88
Table 48: Seasonal Influenza Vaccine Market, Philippines, Number of Doses Forecast (million), 2011-2018 89
Table 49: Seasonal Influenza Vaccine Market, Singapore, Revenue Forecast ($m), 2011-2018 93
Table 50: Seasonal Influenza Vaccine Market, Singapore, Vaccination Cost Forecast ($), 2011-2018 94
Table 51: Seasonal Influenza Vaccine Market, Singapore, Population Forecast by Age Group (million), 2011-2018 95
Table 52: Seasonal Influenza Vaccine Market, Singapore, Vaccinated Population Forecast by Age Group (%), 2011-2018 96
Table 53: Seasonal Influenza Vaccine Market, Singapore, Vaccination Coverage Forecast (‘000), 2011-2018 97
Table 54: Seasonal Influenza Vaccine Market, Singapore, Number of Doses Forecast by Age Group (‘000), 2011-2018 98
Table 55: Seasonal Influenza Vaccine Market, Taiwan, Revenue Forecast ($m), 2011-2018 103
Table 56: Seasonal Influenza Vaccine Market, Taiwan, Vaccination Cost Forecast ($), 2011-2018 104
Table 57: Seasonal Influenza Vaccine Market, Taiwan, Population Forecast by Age Group (million), 2011-2018 105
Table 58: Seasonal Influenza Vaccine Market, Taiwan, Vaccinated Population Forecast by Age Group (%), 2011-2018 106
Table 59: Seasonal Influenza Vaccine Market, Taiwan, Vaccination Coverage Forecast by Age Group (million), 2011-2018 107
Table 60: Seasonal Influenza Vaccine Market, Taiwan, Number of Doses Forecast by Age Group (million), 2011-2018 108
Table 61: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Filed, 2012 112
Table 62: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Phase III, 2012 112
Table 63: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Phase II, 2012 113
Table 64: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Phase I, 2012 114
Table 65: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Preclinical, 2012 115
Table 66: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Discovery Phase, 2012 115
Table 67: Seasonal Influenza Vaccine Market, APAC Region, Most Promising Vaccines in Clinical Development, 2012 116
Table 68: Seasonal Influenza Vaccine Market, APAC Region, Major MandA Deals, 2007-2012 123



List of Figures

Figure 1: Seasonal Influenza Vaccine Market, APAC Region, Revenue Forecast ($m), 2011-2018 14
Figure 2: Seasonal Influenza Vaccine Market, APAC Region, Revenue Forecast by Geography ($bn), 2011-2018 15
Figure 3: Seasonal Influenza Vaccine Market, Australia, Regulatory Authorities, 2012 17
Figure 4: Seasonal Influenza Vaccine Market, Australia, Drug Approval Process, 2011 18
Figure 5: Seasonal Influenza Vaccine Market, Australia, Revenue Forecast ($m), 2011-2018 20
Figure 6: Seasonal Influenza Vaccine Market, Australia, Vaccination Cost Forecast ($), 2011-2018 21
Figure 7: Seasonal Influenza Vaccine Market, Australia, Population Forecast by Age Group (million), 2011-2018 22
Figure 8: Seasonal Influenza Vaccine Market, Australia, Vaccinated Population Forecast by Age Group (%), 2011-2018 23
Figure 9: Seasonal Influenza Vaccine Market, Australia, Number of Doses Forecast by Age Group (million), 2011-2018 25
Figure 10: Seasonal Influenza Vaccine Market, Australia, Drivers and Barriers, 2012 26
Figure 11: Seasonal Influenza Vaccine Market, China, Regulatory Authorities, 2011 27
Figure 12: Seasonal Influenza Vaccine Market, China, New Drug Registration Process, 2011 28
Figure 13: Seasonal Influenza Vaccine Market, China, Revenue Forecast ($m), 2011-2018 29
Figure 14: Seasonal Influenza Vaccine Market, China, Vaccination Cost Forecast ($), 2011-2018 30
Figure 15: Seasonal Influenza Vaccine Market, China, Population Forecast by Age Group (million), 2011-2018 31
Figure 16: Seasonal Influenza Vaccine Market, China, Vaccinated Population Forecast (%), 2011-2018 32
Figure 17: Seasonal Influenza Vaccine Market, China, Number of Doses Forecast (million), 2011-2018 34
Figure 18: Seasonal Influenza Vaccine Market, China, Drivers and Barriers, 2012 35
Figure 19: Seasonal Influenza Vaccine Market, Hong Kong, Regulatory Authorities, 2011 36
Figure 20: Seasonal Influenza Vaccine Market, Hong Kong, Drug Approval Process, 2011 37
Figure 21: Seasonal Influenza Vaccine Market, Hong Kong, Revenue Forecast ($m), 2011-2018 38
Figure 22: Seasonal Influenza Vaccine Market, Hong Kong, Vaccination Cost Forecast ($), 2011-2018 39
Figure 23: Seasonal Influenza Vaccine Market, Hong Kong, Population Forecast by Age Group (million), 2011-2018 40
Figure 24: Seasonal Influenza Vaccine Market, Hong Kong, Vaccinated Population Forecast by Age Group (%), 2011-2018 41
Figure 25: Seasonal Influenza Vaccine Market, Hong Kong, Number of Doses Forecast by Age Group (‘000), 2011-2018 43
Figure 26: Seasonal Influenza Vaccine Market, Hong Kong, Market Share by Company (%), 2012 44
Figure 27: Seasonal Influenza Vaccine Market, Hong Kong, Drivers and Barriers, 2012 45
Figure 28: Seasonal Influenza Vaccine Market, India, Regulatory Authority, 2011 46
Figure 29: Seasonal Influenza Vaccine Market, India, Common Technical Document Application, 2011 47
Figure 30: Seasonal Influenza Vaccine Market, India, Drug Approval Process, 2011 48
Figure 31: Seasonal Influenza Vaccine Market, India, Revenue Forecast ($m), 2011-2018 49
Figure 32: Seasonal Influenza Vaccine Market, India, Vaccination Cost Forecast ($), 2011-2018 50
Figure 33: Seasonal Influenza Vaccine Market, India, Drivers and Barriers, 2012 51
Figure 34: Seasonal Influenza Vaccine Market, Japan, Regulatory Authorities, 2012 52
Figure 35: Seasonal Influenza Vaccine Market, Japan, Drug Approval Process, 2012 53
Figure 36: Seasonal Influenza Vaccine Market, Japan, Revenue Forecast ($m), 2011-2018 54
Figure 37: Seasonal Influenza Vaccine Market, Japan, Population Forecast by Age Group (million), 2011-2018 56
Figure 38: Seasonal Influenza Vaccine Market, Japan, Vaccination Coverage Forecast by Age Group (%), 2011-2018 57
Figure 39: Seasonal Influenza Vaccine Market, Japan, Number of Doses Forecast by Age Group (million), 2011-2018 59
Figure 40: Seasonal Influenza Vaccine Market, Japan, Drivers and Barriers, 2012 60
Figure 41: Seasonal Influenza Vaccine Market, Malaysia, Regulatory Authorities, 2011 62
Figure 42: Seasonal Influenza Vaccine Market, Malaysia, Drug Approval Process, 2011 63
Figure 43: Seasonal Influenza Vaccine Market, Malaysia, Revenue Forecast ($m), 2011-2018 64
Figure 44: Seasonal Influenza Vaccine Market, Malaysia, Vaccination Cost Forecast ($), 2011-2018 65
Figure 45: Seasonal Influenza Vaccine Market, Malaysia, Population Forecast by Age Group (million), 2011-2018 66
Figure 46: Seasonal Influenza Vaccine Market, Malaysia, Vaccinated Population Forecast by Age Group (%), 2011-2018 67
Figure 47: Seasonal Influenza Vaccine Market, Malaysia, Number of Doses Forecast by Age Group (‘000), 2011-2018 69
Figure 48: Seasonal Influenza Vaccine Market, Malaysia, Market Share by Company (%), 2012 70
Figure 49: Seasonal Influenza Vaccine Market, Malaysia, Drivers and Barriers, 2012 71
Figure 50: Seasonal Influenza Vaccine Market, New Zealand, Regulatory Authorities, 2011 72
Figure 51: Seasonal Influenza Vaccine Market, New Zealand, Drug Approval Process, 2011 73
Figure 52: Seasonal Influenza Vaccine Market, New Zealand, Revenue Forecast ($m), 2011-2018 74
Figure 53: Seasonal Influenza Vaccine Market, New Zealand, Vaccination Cost Forecast ($), 2011-2018 75
Figure 54: Seasonal Influenza Vaccine Market, New Zealand, Population by Age Group Forecast (million), 2011-2018 76
Figure 55: Seasonal Influenza Vaccine Market, New Zealand, Vaccinated Population Forecast (%), 2011-2018 77
Figure 56: Seasonal Influenza Vaccine Market, New Zealand, Number of Doses Forecast (‘000), 2011-2018 79
Figure 57: Seasonal Influenza Vaccine Market, New Zealand, Market Share by Company (%), 2012 80
Figure 58: Seasonal Influenza Vaccine Market, New Zealand, Drivers and Barriers, 2012 81
Figure 59: Seasonal Influenza Vaccine Market, Philippines, Regulatory Authorities, 2011 82
Figure 60: Seasonal Influenza Vaccine Market, Philippines, Drug Approval Process, 2011 83
Figure 61: Seasonal Influenza Vaccine Market, Philippines, Revenue Forecast ($m), 2011-2018 84
Figure 62: Seasonal Influenza Vaccine Market, Philippines, Vaccination Cost Forecast ($m), 2011-2018 85
Figure 63: Seasonal Influenza Vaccine Market, Philippines, Population Forecast (million), 2011-2018 86
Figure 64: Seasonal Influenza Vaccine Market, Philippines, Vaccinated Population Forecast (%), 2011-2018 87
Figure 65: Seasonal Influenza Vaccine Market, Philippines, Number of Doses Forecast (million), 2011-2018 89
Figure 66: Seasonal Influenza Vaccine Market, Philippines, Market Share by Company (%), 2012 90
Figure 67: Seasonal Influenza Vaccine Market, Philippines, Drivers and Barriers, 2012 91
Figure 68: Seasonal Influenza Vaccine Market, Singapore, Regulatory Authorities, 2011 92
Figure 69: Seasonal Influenza Vaccine Market, Singapore, Drug Approval Process, 2011 92
Figure 70: Seasonal Influenza Vaccine Market, Singapore, Revenue Forecast ($m), 2011-2018 93
Figure 71: Seasonal Influenza Vaccine Market, Singapore, Vaccination Cost Forecast ($), 2011-2018 94
Figure 72: Seasonal Influenza Vaccine Market, Singapore, Population Forecast by Age Group (million), 2011-2018 95
Figure 73: Seasonal Influenza Vaccine Market, Singapore, Vaccinated Population Forecast by Age Group (%), 2011-2018 96
Figure 74: Seasonal Influenza Vaccine Market, Singapore, Number of Doses Forecast by Age Group (‘000), 2011-2018 98
Figure 75: Seasonal Influenza Vaccine Market, Singapore, Market Share by Company (%), 2012 99
Figure 76: Seasonal Influenza Vaccine Market, Singapore, Drivers and Barriers, 2012 100
Figure 77: Seasonal Influenza Vaccine Market, Taiwan, Regulatory Authorities, 2011 101
Figure 78: Seasonal Influenza Vaccine Market, Taiwan, Drug Approval Process, 2011 102
Figure 79: Seasonal Influenza Vaccine Market, Taiwan, Revenue Forecast ($m), 2011-2018 103
Figure 80: Seasonal Influenza Vaccine Market, Taiwan, Vaccination Cost Forecast ($), 2011-2018 104
Figure 81: Seasonal Influenza Vaccine Market, Taiwan, Population Forecast by Age Group (million), 2011-2018 105
Figure 82: Seasonal Influenza Vaccine Market, Taiwan, Vaccinated Population Forecast by Age Group (%), 2011-2018 106
Figure 83: Seasonal Influenza Vaccine Market, Taiwan, Number of Doses Forecast by Age Group (million), 2011-2018 108
Figure 84: Seasonal Influenza Vaccine Market, Taiwan, Market Share by Company (%), 2012 109
Figure 85: Seasonal Influenza Vaccine Market, Taiwan, Drivers and Barriers, 2012 110
Figure 86: Seasonal Influenza Vaccine Market, APAC Region, Pipeline by Phase (%), 2012 111
Figure 87: Seasonal Influenza Vaccine Market, APAC Region, MandA Deals by Geography (%), 2007-2012 126
Figure 88: Seasonal Influenza Vaccine Market, APAC Region, Licensing Agreements by Geography, (%), 2007-2012 130
Figure 89: GBI Research Market Forecasting Model 136



Companies Mentioned

Sanofi Pasteur
GlaxoSmithKline Biologicals
Abbott Laboratories (Solvay Pharmaceuticals)
CSL Biotherapies
Novartis Vaccines
Crucell N.V. (Berna Biotech)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025

EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025

  • $ 3995
  • Industry report
  • November 2016
  • by Global Data

EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025 Summary Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses resulting in mild to severe ...

Global and Chinese Influenza Vaccine (Split Virion),Inactivated Industry, 2016 Market Research Report

Global and Chinese Influenza Vaccine (Split Virion),Inactivated Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Influenza Vaccine (Split Virion),Inactivated Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Influenza Vaccine ...

Global and Chinese Influenza Vaccine (Whole Virion),Inactivated Industry, 2016 Market Research Report

Global and Chinese Influenza Vaccine (Whole Virion),Inactivated Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Influenza Vaccine (Whole Virion),Inactivated Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Influenza Vaccine ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in New Zealand - Forecast

  • December 2016
    71 pages
  • Therapy  

  • New Zealand  

View report >

Anti-Infective and Therapy Market in the US - Forecast

  • December 2016
    249 pages
  • Anti-Infective  

    Therapy  

    Hormone  

  • United States  

View report >

Influenza Statistics in France

  • November 2016
    23 pages
  • Influenza  

    Infectious Dise...  

    Vaccine  

  • France  

    Europe  

View report >

Global Vaccine Supply

23 days ago

Related Market Segments :

Influenza Vaccine
Vaccine

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.